Search research articles
Contact Us
Filters
Showing results (261-270 of 387) with videos related to
Page
of 39
Sort By:
Microbiology Spectrum
|
April 4, 2022
Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up
Maria Francesca Cortese, Mar Riveiro-Barciela, David Tabernero, et al.
Gut
|
August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Microorganisms
|
May 25, 2024
In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications
Josep Gregori, Sergi Colomer-Castell, Marta Ibañez-Lligoña, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2019
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1
Stefan Zeuzem, Stefan Bourgeois, Susan Greenbloom, et al.
The Journal of Infectious Diseases
|
April 23, 2020
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study
Milan J Sonneveld, Bettina E Hansen, Willem P Brouwer, et al.
Alimentary Pharmacology & Therapeutics
|
June 28, 2021
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Adriana Palom, Sara Sopena, Mar Riveiro-Barciela, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)
Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology
|
September 9, 2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V Papatheodoridis, George N Dalekos, Cihan Yurdaydin, et al.
Scientific Reports
|
July 21, 2019
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients
Ondrej Podlaha, Edward Gane, Maurizia Brunetto, et al.
Antimicrobial Agents and Chemotherapy
|
July 25, 2018
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection
Andrea L Cathcart, Henry Lik-Yuen Chan, Neeru Bhardwaj, et al.
Page
of 39
Search research articles
Search
Showing results (261-270 of 387) with videos related to
Sort By:
Page
of 39
Microbiology Spectrum
|
April 4, 2022
Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up
Maria Francesca Cortese, Mar Riveiro-Barciela, David Tabernero, et al.
Gut
|
August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Microorganisms
|
May 25, 2024
In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications
Josep Gregori, Sergi Colomer-Castell, Marta Ibañez-Lligoña, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2019
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1
Stefan Zeuzem, Stefan Bourgeois, Susan Greenbloom, et al.
The Journal of Infectious Diseases
|
April 23, 2020
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study
Milan J Sonneveld, Bettina E Hansen, Willem P Brouwer, et al.
Alimentary Pharmacology & Therapeutics
|
June 28, 2021
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Adriana Palom, Sara Sopena, Mar Riveiro-Barciela, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)
Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology
|
September 9, 2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V Papatheodoridis, George N Dalekos, Cihan Yurdaydin, et al.
Scientific Reports
|
July 21, 2019
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients
Ondrej Podlaha, Edward Gane, Maurizia Brunetto, et al.
Antimicrobial Agents and Chemotherapy
|
July 25, 2018
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection
Andrea L Cathcart, Henry Lik-Yuen Chan, Neeru Bhardwaj, et al.
Page
of 39